Axa S.A. Moderna, Inc. Transaction History
Axa S.A.
- $29.5 Billion
- Q1 2025
A detailed history of Axa S.A. transactions in Moderna, Inc. stock. As of the latest transaction made, Axa S.A. holds 167,024 shares of MRNA stock, worth $4.44 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
167,024
Previous 169,182
1.28%
Holding current value
$4.44 Million
Previous $7.03 Million
32.68%
% of portfolio
0.02%
Previous 0.02%
Shares
26 transactions
Others Institutions Holding MRNA
# of Institutions
861Shares Held
251MCall Options Held
23.9MPut Options Held
30.2M-
Vanguard Group Inc Valley Forge, PA40.4MShares$1.07 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY25.6MShares$680 Million0.07% of portfolio
-
Baillie Gifford & CO22.1MShares$588 Million0.48% of portfolio
-
State Street Corp Boston, MA17.8MShares$473 Million0.02% of portfolio
-
Geode Capital Management, LLC Boston, MA8.88MShares$236 Million0.02% of portfolio
About Moderna, Inc.
- Ticker MRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 391,200,000
- Market Cap $10.4B
- Description
- Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...